As a key tumor suppressor gene involved in the regulation of the cell cycle, apoptosis, senescence, and DNA repair, somatic TP53 mutations are estimated to occur in 20–30% of cancer cases, including breast cancer (31, 32). Here, TP53 is linked to breast carcinoma.